Global Distribution of Human Protoparvoviruses
Elina Väisänen, Ushanandini Mohanraj, Paula M. Kinnunen
1, Pikka Jokelainen, Haider Al-Hello, Ali M. Barakat, Mohammadreza Sadeghi
2, Farid A. Jalilian, Amir Majlesi, Moses Masika, Dufton Mwaengo, Omu Anzala, Eric Delwart, Olli Vapalahti, Klaus Hedman, and Maria Söderlund-Venermo
Author affiliations: University of Helsinki, Helsinki, Finland (E. Väisänen, U. Mohanraj, P.M. Kinnunen, P. Jokelainen, O. Vapalahti, K. Hedman, M. Söderlund-Venermo); Statens Serum Institut, Copenhagen, Denmark (P. Jokelainen); Estonian University of Life Sciences, Tartu, Estonia (P. Jokelainen); National Institute for Health and Welfare, Helsinki (H. Al-Hello); Al-Hussein Teaching Hospital, Thi-Qar Governorate, Iraq (A.M. Barakat); Blood Systems Research Institute, San Francisco, California, USA (M. Sadeghi, E. Delwart); University of California, San Francisco (M. Sadeghi, E. Delwart); Hamadan University of Medical Sciences, Hamadan, Iran (F.A. Jalilian, A. Majlesi); University of Nairobi, Nairobi, Kenya (M. Masika, D. Mwaengo, O. Anzala); Helsinki University Hospital, Helsinki (O. Vapalahti, K. Hedman)
Main Article
Figure 1
Figure 1. Identification of cutavirus from human serum samples. A) Sodium dodecyl sulfate–polyacrylamide gel electrophoresis of virus capsid protein 2. Lane M, protein size marker; lane C, cutavirus. B) Electron micrograph of cutavirus virus-like particles. Scale bar indicates 100 nm.
Main Article
Page created: June 18, 2018
Page updated: June 18, 2018
Page reviewed: June 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.